Work

Serum Galectin-10: A biomarker for persistent airflow limitation in adult asthmatics

Year: 2024

Type: article

Abstract: Background Inhaled corticosteroids (ICS) are primary anti-inflammatory medications to control eosinophilic airway inflammation, and prevent asthma exacerbation. However, persistent airflow limitation (PAL) presents in some asthmatics even on ICS treatment, leading to lung function decline. Thus, we evaluated clinical associations of serum galectin-10 (Gal10) and galectin-3 (Gal3) levels in adult asthmatics who had maintained anti-asthma medication. Methods Sixty-seven asthmatics and 78 healthy controls (HCs) were recruited. Serum Gal10 and Gal3 levels were measured by enzyme-linked immunosorbent assay, and their clinical relevance with inflammatory and lung function parameters was evaluated. Spirometry was performed to assess PAL and small airway dysfunction (SAD). Airway epithelial cells were cocultured with eosinophils/neutrophils, and were exposed to house dust mites to assess the production of Gal10 and Gal3. Results Serum Gal10 (not Gal3) levels were significantly higher in asthmatics than in HCs ( P < 0.001), in asthmatics with PAL than in those without PAL ( P = 0.005), and in those with SAD than in those without SAD ( P = 0.004). The Gal10-high group had significantly higher levels of peripheral CD66 + neutrophil counts, serum periostin and Gal3, and lower values of FEV 1 % and MMEF% than the Gal10-low group ( P < 0.050 for all). The production of Gal10 and Gal3 was increased in eosinophilic airway model, while Gal10 (not Gal3) levels were increased in neutrophilic airway model as well as house dust mite stimulation. Conclusion Our findings suggest that serum Gal10 level may be a potential biomarker for PAL in adult asthmatics.

Source: World Allergy Organization Journal

DOI: 10.1016/j.waojou.2024.100955